CORTELEZZI, AGOSTINO
CORTELEZZI, AGOSTINO
Dipartimento di Oncologia ed Emato-Oncologia
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial
2020 L. Cicconi, U. Platzbecker, G. Avvisati, F. Paoloni, C. Thiede, M. Vignetti, P. Fazi, F. Ferrara, M. Divona, F. Albano, F. Efficace, M. Sborgia, E. Di Bona, M. Breccia, E. Borlenghi, R. Cairoli, A. Rambaldi, L. Melillo, G. La Nasa, W. Fiedler, P. Brossart, B. Hertenstein, H.R. Salih, O. Annibali, M. Wattad, M. Lubbert, C.H. Brandts, M. Hanel, C. Rollig, N. Schmitz, H. Link, C. Frairia, C. Fozza, A. Maria D'Arco, N. Di Renzo, A. Cortelezzi, F. Fabbiano, K. Dohner, A. Ganser, H. Dohner, S. Amadori, F. Mandelli, M.T. Voso, G. Ehninger, R.F. Schlenk, F. Lo-Coco
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06
2020 C. Caprioli, F. Lussana, S. Salmoiraghi, R. Cavagna, K. Buklijas, L. Elidi, P. Zanghi', A. Michelato, F. Delaini, E. Oldani, T. Intermesoli, A. Grassi, G. Gianfaldoni, F. Mannelli, D. Ferrero, E. Audisio, E. Terruzzi, L. De Paoli, C. Cattaneo, E. Borlenghi, I. Cavattoni, M. Tajana, A.M. Scattolin, D. Mattei, P. Corradini, L. Campiotti, F. Ciceri, M. Bernardi, E. Todisco, A. Cortelezzi, B. Falini, C. Pavoni, R. Bassan, O. Spinelli, A. Rambaldi
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years : NILG ALL 10/07
2020 R. Bassan, C. Pavoni, T. Intermesoli, O. Spinelli, M. Tosi, E. Audisio, F. Marmont, C. Cattaneo, E. Borlenghi, S. Cortelazzo, I. Cavattoni, M. Fumagalli, D. Mattei, C. Romani, A. Cortelezzi, N. Fracchiolla, F. Ciceri, M. Bernardi, A.M. Scattolin, L. Depaoli, A. Masciulli, E. Oldani, A. Rambaldi
IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia
2019 G. Reda, R. Cassin, M. Gentile, F.R. Mauro, D. Giannarelli, B. Fattizzo, M. Barbieri, I. Silvestris, S. Fabris, F. Morabito, A. Neri, W. Barcellini, A. Cortelezzi
Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL)
2019 R. Cassin, V. Mattiello, M. Viltadi, D. D'Aliberti, R. Piazza, C. Gambacorti-Passerini, U. Gianelli, A. Neri, A. Cortelezzi, G. Reda
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (Gitmo)
2019 A. Candoni, A. Rambaldi, R. Fanin, A. Velardi, W. Arcese, F. Ciceri, D. Lazzarotto, F. Lussana, J. Olivieri, G. Grillo, M. Parma, B. Bruno, F. Sora, P. Bernasconi, R. Saccardi, R. Foà, M. Sessa, P. Bresciani, F. Giglio, A. Picardi, A. Busca, S. Sica, K. Perruccio, E. Zucchetti, E. Diral, A.P. Iori, A.A. Colombo, S. Tringali, S. Santarone, G. Irrera, S. Mancini, F. Zallio, M. Malagola, F. Albano, A.M. Carella, A. Olivieri, C. Tecchio, A. Dominietto, A. Vacca, R. Sorasio, E. Orciuolo, A.M. Risitano, S.N. Leotta, A. Cortelezzi, S. Mammoliti, E. Oldani, F. Bonifazi
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML
2019 R. Bassan, T. Intermesoli, A. Masciulli, C. Pavoni, C. Boschini, G. Gianfaldoni, F. Marmont, I. Cavattoni, D. Mattei, E. Terruzzi, L. De Paoli, C. Cattaneo, E. Borlenghi, F. Ciceri, M. Bernardi, A.M. Scattolin, E. Todisco, L. Campiotti, P. Corradini, A. Cortelezzi, D. Ferrero, P. Zanghì, E. Oldani, O. Spinelli, E. Audisio, S. Cortelazzo, A. Bosi, B. Falini, E.M. Pogliani, A. Rambaldi
Heterogeneity among different myeloproliferative neoplasms associated with splanchnic vein thrombosis
2018 D. Cattaneo, N. Orofino, C. Bucelli, V. Mattiello, P. Bianchi, U. Gianelli, A. Cortelezzi, A. Iurlo
Prevalence and clinical significance of small PNH clones in patiens with primary autoimmune hemolytic anemia
2018 B. Fattizzo, A. Zaninoni, R. Pasquale, L. Cro, A. Dunlop, A. Cortelezzi, A. Kulasekararaj, W. Barcellini
Heterogeneity among splanchnic vein thrombosis associated with myeloproliferative neoplasms
2018 D. Cattaneo, U. Gianelli, P. Bianchi, A. Cortelezzi, A. Iurlo
Autoimmune hemolytic anemia, autoimmune neutropenia and aplastic anemia in the elderly
2018 W. Barcellini, B. Fattizzo, A. Cortelezzi
Immunoglobulin heavy chain variable region gene (IGHV) and prediction of time to first treatment (TTFT) in patients with chronic lymphocytic leukemia (CLL): Mutational load or mutational status? Analysis of 1003 cases
2018 F. Morabito, T.D. Shanafelt, M. Gentile, G. Reda, F.R. Mauro, D. Rossi, N. Di Renzo, S. Molica, F. Angrilli, A. Chiarenza, G. Cutrona, K.G. Chaffee, S.A. Parikh, G. Tripepi, G. D'Arrigo, E. Vigna, A.G. Recchia, A. Cortelezzi, G. Gaidano, F. Di Raimondo, F. Fais, R. Foà, A. Neri, M. Ferrarini
Secondary acute myeloid leukaemia in elderly patients : Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions : an analysis of 280 patients by the network rete ematologica lombarda (REL)
2018 E. Borlenghi, C. Pagani, P. Zappasodi, M. Bernardi, C. Basilico, E. Todisco, N. Fracchiolla, V. Mancini, M. Turrini, M. Da Vià, E. Sala, C. Cattaneo, M. Petullà, F. Serana, A. Ferrario, R. Cairoli, A. Cortelezzi, A. Santoro, C. Castagnola, G. Rossi
Paroxysmal Nocturnal Hemoglobinuria (Pnh) : Brain Mri Ischemic Lesions in Neurologically Asymtomatic Patients
2018 W. Barcellini, E. Scola, S. Lanfranconi, M. Grottaroli, F. Binda, B. Fattizzo, A. Zaninoni, G. Valcamonica, C.M. Cinnante, C. Boschetti, M. Buoli, C.A. Altamura, N. Bresolin, F. Triulzi, A. Zanella, A. Cortelezzi
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms
2018 V. De Stefano, A. Carobbio, V. Di Lazzaro, P. Guglielmelli, A. Iurlo, M.C. Finazzi, E. Rumi, F. Cervantes, E.M. Elli, M.L. Randi, M. Griesshammer, F. Palandri, M. Bonifacio, J.-. Hernandez-Boluda, R. Cacciola, P. Miroslava, G. Carli, E. Beggiato, M.H. Ellis, C. Musolino, G. Gaidano, D. Rapezzi, A. Tieghi, F. Lunghi, G.G. Loscocco, D. Cattaneo, A. Cortelezzi, S. Betti, E. Rossi, G. Finazzi, B. Censori, M. Cazzola, M. Bellini, E. Arellano-Rodrigo, I. Bertozzi, P. Sadjadian, N. Vianelli, L. Scaffidi, M. Gomez, E. Cacciola, A.M. Vannucchi, T. Barbui
Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasias
2018 B. Gerber, M. Manzoni, V. Spina, A. Bruscaggin, M. Lionetti, S. Fabris, M. Barbieri, G. Ciceri, A. Pompa, G. Forestieri, E. Lerch, P. Servida, F. Bertoni, E. Zucca, M. Ghielmini, A. Cortelezzi, F. Cavalli, G. Stussi, L. Baldini, D. Rossi, A. Neri
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment
2018 M. Gentile, T.D. Shanafelt, F.R. Mauro, G. Reda, D. Rossi, L. Laurenti, M.I. Del Principe, G. Cutrona, I. Angeletti, M. Coscia, Y. Herishanu, A. Chiarenza, S. Molica, S. Ciolli, N. Goldschmidt, F. Angrilli, A. Giordano, A. Rago, O. Bairey, G. Tripepi, K.G. Chaffee, P.A. Sameer, E. Vigna, K. Zirlik, L. Shvidel, I. Innocenti, A.G. Recchia, F. Di Raimondo, G. Del Poeta, A. Cortelezzi, A. Neri, M. Ferrarini, G. Gaidano, N.E. Kay, A. Polliack, R. Foà, F. Morabito
Severe hypofibrinogenemia associated with imatinib and prednisone therapy in Philadelphia chromosome–positive acute lymphoblastic leukemia
2018 M. Sciumè, N.S. Fracchiolla, A. Cortelezzi
Predictors of atrial fibrillation in ibrutinib-treated CLL patients : a prospective study
2018 G. Reda, B. Fattizzo, R. Cassin, V. Mattiello, T. Tonella, D. Giannarelli, F. Massari, A. Cortelezzi
Prognostic impact of bone marrow fibrosis and dyserythropoiesis in autoimmune hemolytic anemia
2018 B. Fattizzo, A. Zaninoni, U. Gianelli, A. Zanella, A. Cortelezzi, A.G. Kulasekararaj, W. Barcellini